SARS_CoV_2 mutation literature information.


  Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
 PMID: 35101265       2022       Vaccine
Table: S13I


  Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
 PMID: 34801754       2022       Infection, genetics and evolution
Result: 5D) share the same set of mutations on the
Result: S13I and L452R were detected separately in previous sequences, but W152C was not.
Figure: L18F, E484K, N501Y, D614G, H655Y, and V1176F are associated with the Gamma variant of concern, and S13I, W152C, L452R are associated with the Epsilon variant of concern.


  Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco.
 PMID: 33788923       2022       Clinical infectious diseases
Abstract: Certain viral lineages bearing spike mutations, defined in part by L452R, S13I, and W152C, comprised 54.4% of the total sequences from January, compared to 15.7% in November.


  Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.
 PMID: 34906769       2022       Biomedicine & pharmacotherapy
Table: S13I


  The Emergence and Spread of Novel SARS-CoV-2 Variants.
 PMID: 34409009       2021       Frontiers in public health
Result: The mutations of S protein include S13I, W152C, and L452R.


  Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies.
 PMID: 34484190       2021       Frontiers in immunology
Introduction: In addition, several recent studies have focused on the neutralizing activity of vaccine-elicited humoral immunity against new circulating mutant lineages, including B.1.1.7 (United Kingdom, bearing mutations 69-70 del, 144 del, N501Y, A570D, D614G, P681H, T716I, S982A, and D1118H in the spike protein), B.1.429 (United States, bearing mutations S13I, W152C, L452R, and D614G in the spike protein), B.1.351(South Africa, bearing mutations D80A, D215G,  PMID: 34458642       2021       Heliyon
Figure: Mutated amino acid positions shown in the human ACE2 receptor bound structure (PDB ID: 6acj) of SARS-CoV-2 spike protein (except L5F, S13I, Q14H, G75V, T76I, Y145del, H146Y, Q675 H/R, Q677H, N679K, I834V, R1185H and K1195N as the regions were not covered in the structure).


  Community-level SARS-CoV-2 sequence diversity revealed by wastewater sampling.
 PMID: 34438144       2021       The Science of the total environment
Table: S13I


  Conformational Variability Correlation Prediction of Transmissibility and Neutralization Escape Ability for Multiple Mutation SARS-CoV-2 Strains using SSSCPreds.
 PMID: 34337269       2021       ACS omega
Introduction: In January 2021, novel strains B.1.427/429, which contain S13I, W152C, L452R, and D614G mutations in the spike protein, were found in California (Figure 1A).


  GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
 PMID: 34388530       2021       Biomedicine & pharmacotherapy
Discussion: For epsilon variant, the two B.1.427 and B.1.429 lineages have the same spike protein mutations, inclunding S13I and W152C in the NTD and L452R in the RBD.



Browser Board

 Co-occurred Entities




   Filtrator